|
Volumn 44, Issue 4, 1999, Pages 455-
|
Balsalazide led to greater remission rates and tolerance than mesalamine in acute ulcerative colitis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BALSALAZIDE;
HYDROCORTISONE ACETATE;
MESALAZINE;
ADULT;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG TOLERANCE;
FECES ANALYSIS;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
NOTE;
ORAL DRUG ADMINISTRATION;
OUTCOMES RESEARCH;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RECTAL DRUG ADMINISTRATION;
REMISSION;
SIDE EFFECT;
SIGMOIDOSCOPY;
ULCERATIVE COLITIS;
|
EID: 0032900780
PISSN: 00175749
EISSN: None
Source Type: Journal
DOI: 10.1136/gut.44.4.455 Document Type: Note |
Times cited : (6)
|
References (2)
|